REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 42
08/03/2016 12:10
- Part 42: For the preceding part double click ID:nRSH4027RO
since February 2006. In addition, where claims are made under insurance
policies, insurers may reserve the right to deny coverage on various
grounds. For example, product liability litigation cases relating to
Crestor and Nexium in the US are not covered by third party product
liability insurance. See Note 27 to the Financial Statements from page
186 for details. TaxationThe integrated nature of our worldwide
operations can produce conflicting claims from revenue authorities as to
the profits to be taxed in individual countries. The majority of the
jurisdictions in which we operate have double tax treaties with other
foreign jurisdictions, which provide a framework for mitigating the
incidence of double taxation on our revenues and capital gains.
AstraZeneca's worldwide operations are taxed under laws in the
- More to follow, for following part double click ID:nRSH4027RQRecent news on AstraZeneca
See all newsRCS - LHH - LHH, EZRA's AI Leadership Transformation Program
AnnouncementREG - AstraZeneca PLC - Baxdrostat met primary endpoint in Bax24 Ph3 trial
AnnouncementREG - AstraZeneca PLC - Datroway improved OS and PFS in TROPION-Breast02
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Enhertu improved IDFS in early BC in DB-05
Announcement